Related Experiment Video
Updated: Jul 29, 2026
06:32
Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice
Published on: September 19, 2016
HLA-A and -B antigens in chronic bronchitis
U Anagnostopoulou1, M Toumbis, K Konstantopoulos
1Athens Chest Diseases Hospital, Greece.
Journal of Clinical Epidemiology
|December 1, 1993
Summary
Genetic factors, specifically Human Leucocyte Antigens (HLA), may play a role in chronic bronchitis. This study found increased HLA-A1 and HLA-B17 in Greek patients, suggesting a genetic link to the disease.
Area of Science:
- Immunogenetics
- Respiratory Medicine
- Human Genetics
Background:
- Chronic bronchitis is a prevalent respiratory condition with complex etiology.
- The role of genetic predisposition in chronic bronchitis remains an area of active investigation.
- Human Leucocyte Antigens (HLA) are crucial for immune regulation and have been implicated in various diseases.
Purpose of the Study:
- To investigate the association between specific Human Leucocyte Antigens (HLA) and chronic bronchitis in a Greek population.
- To explore potential genetic factors contributing to the pathogenesis of chronic bronchitis.
Main Methods:
- Human Leucocyte Antigen (HLA) typing was performed on Greek patients diagnosed with chronic bronchitis.
- Results were compared against a control group of 400 healthy unrelated individuals from the same population, including smokers and non-smokers.
- Statistical analysis was employed to determine significant associations.
Main Results:
- A statistically significant increase in the prevalence of HLA-A1 and HLA-B17 was observed in patients with chronic bronchitis compared to the general healthy population.
- This association remained significant even when healthy smokers were used as the exclusive control group.
- The findings suggest a potential genetic susceptibility linked to these specific HLA types.
Conclusions:
- The study provides evidence supporting the hypothesis that genetic factors, specifically certain Human Leucocyte Antigens (HLA), are involved in the pathogenesis of chronic bronchitis.
- HLA-A1 and HLA-B17 may represent genetic markers associated with an increased risk for developing chronic bronchitis.
- Further research is warranted to elucidate the precise mechanisms by which these genetic factors influence disease development.
More Related Videos
Related Concept Videos
01:26Antigens Involved in Adaptive Immunity
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
01:28Asthma I: Introduction
Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
01:23Chronic Obstructive Pulmonary Disease I: Introduction
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
01:23Chronic Obstructive Pulmonary Disease II: Emphysema
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...